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Abstract 
Objective—Using combined individual patient data (IPD) from prospective studies, we 
explored sex differences in depression and prognosis post-myocardial infarction (MI), 
and determined whether disease indices could account for found differences. 
Methods—Meta-analysis of IPD from 10,175 MI patients who completed diagnostic 
interviews or depression questionnaires from 16 prospective studies of MI patients, 
identified by systematic review for the MINDMAPS study. Multilevel logistic and Cox 
regression models were used to determine sex differences in prevalence of depression and 
sex-specific effects of depression on subsequent cardiovascular morbidity and all-
cause mortality.  
Results—Combined interview and questionnaire data from observational studies showed 
that 36% (635/1760) of women and 29% (1575/5526) of men reported elevated levels of 
depression (age-adjusted OR=0.68, 95% CI 0.60 to 0.77, p<0.001). The risk for all-cause 
mortality associated with depression was higher in men (HR=1.38, 95% CI 1.30 to 1.47, 
p<0.001) than in women (HR=1.22, 95% CI 1.14 to 1.31, p<0.001) (sex*depression 
interaction p<0.001). Low left ventricular ejection fraction (LVEF) was associated with 
higher depression scores in men only (sex*LVEF interaction B=0.294, 95% CI 0.090 to 
0.498, p=0.005), which attenuated the sex difference in the association between 
depression and prognosis. 
Conclusions— The prevalence of depression post-MI was higher in women than men, but 
the association between depression and cardiac prognosis was worse for men. LVEF was 
associated with depression in men only, and accounted for the increased risk of all-cause 
2 
 
mortality in depressed men versus women, suggesting that depression in men post-MI 
may in part reflect cardiovascular disease severity. 
 
Keywords: Depression; myocardial infarction; gender; prognosis; individual data meta-
analysis 
 
Acronyms 
ACE = angiotensin converting enzyme 
BMI – body mass index 
CABG = coronary artery bypass graft 
CI = confidence interval 
CVE – cardiovascular events 
HF = heart failure 
HR = Hazard ratio 
IPD = Individual patient data 
LVEF = Left ventricular ejection fraction 
MI = myocardial infarction 
OR = odds ratio 
PTCA = percutaneous transluminal coronary intervention 
SD = standard deviation 
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Introduction 
Depression in people with myocardial infarction (MI) has been the source of considerable 
study. While both clinically diagnosed depression and questionnaire-assed depressive 
symptoms have been consistently associated with poorer cardiovascular prognosis in MI 
patients (1), the treatment of depression has not been demonstrated to reduce morbidity or 
mortality in randomized trials (2, 3). Recent estimates suggest a prevalence of diagnosed 
major depressive disorder in the US of 2.1% to 4.9% in adults aged 45 and over (4), with 
women having a higher prevalence (4.8%) than men (3.3%). Similarly, in adults aged 45 
years and above, estimates of elevated depressive symptoms are also more prevalent 
among women (7-12%) than men (5-7%) (5). Similar findings are available for European 
countries (6, 7), although the differing methodologies adopted by different countries 
make overall estimates for major depression more difficult.  According to a systematic 
review of the literature, the prevalence of depression is significantly higher in patients 
with MI, with 20% having major depression and up to 31% reporting elevated depressive 
symptoms, although sex differences were not reported (8).  
 
The etiology of depression post-MI has been the subject of considerable debate. While 
depressive symptoms and trajectories of these symptoms post-MI appear to have similar 
risk factors to depression in the general population (e.g. stressful life events, personality 
etc.) (9-13), sex is not always a predictor of depression in these studies. This suggests that 
there may be a potentially different etiology for depressive symptoms in men and women 
with MI. Indeed, other researchers have demonstrated that elevated levels of depression, 
and its subsequent association with cardiovascular prognosis, may be a consequence of 
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cardiovascular disease severity (14, 15). For example, poor left ventricular ejection 
fraction (LVEF) has been demonstrated to not only correlate with depression, but also to 
predict the onset of major depression and depressive symptoms in patients with MI (14). 
In addition, this study found that poorer LVEF was a stronger predictor of onset of major 
depression for men than for women (14), again suggesting potentially different etiology 
for depression between men and women post-MI.  
 
We aimed to establish whether the prevalence of diagnosed depression and elevated 
depressive symptomatology is similar in men and women with MI, and whether the 
diagnosed depression or depressive symptoms had a greater impact on prognosis for men 
than for women. We also investigated the role of LVEF in the etiology of depression and 
prognosis according to patients’ sex. These questions have not been subject to systematic 
investigation and previous studies were not large enough to detect potential moderating 
effects. We therefore used data from the MINDMAPS individual patient meta-analytic 
database of 16 studies (16) to determine the following: 
1 – whether cardiovascular disease severity indices account for differences in 
post-MI prevalence of depressive symptoms between men and women; and 
2 – whether the association between depression and prognosis is stronger in men 
than in women, and whether disease severity indices (e.g. LVEF) account for 
these differences. 
 
Methods 
MINDMAPS 
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Details of MINDMAPS are available elsewhere (16). In brief, eligibility for inclusion in 
the MINDMAPS dataset was determined by a systematic review of published studies on 
post-MI depression initiated on 5th January 2011 (within 3 months post-hospitalisation 
for MI, assessed by validated questionnaire or diagnostic interview) and two prognostic 
endpoints (all-cause mortality, or major cardiovascular events – CVE: recurrent MI, 
unstable angina, CABG) (1). Authors of all selected studies were contacted and original 
data was requested (covering demographics, depression, disease severity [LVEF<40%, 
Killip class (I vs. II, III, IV), and history of MI], comorbidities, diabetes, smoking, body 
mass index [BMI], medication use, and outcomes). Of 30 eligible studies, 16 provided 
data (16). 
 
Statistical analysis  
Stata 11 was used for the main analyses (Statacorp LP, TX, USA). Multilevel logistic 
regression, adjusting for age, was used to obtain odds ratios (ORs) for differences in 
depression status between men (1) and women (0), using a binary depression variable 
(based on interview or recommended scale thresholds). Hazard ratios (HRs) were 
calculated using multilevel Cox proportional hazards regression analysis, to predict time-
to-event (all-cause mortality or CVE), using depression, sex, and the interaction between 
sex and depression as predictors, adjusting for age. A continuous depression variable was 
used in these Cox analyses (z-transformed total scale scores). As different studies used 
different methods and are likely to represent populations with different characteristics 
(such as date of study, differences in therapies and assessments used, etc.), observations 
within studies are unlikely to be fully independent. Therefore, a random intercept for 
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study was included, resulting in a multilevel model. When calculating the prevalence 
estimates we omitted data from the ENRICHD randomized trial and ancillary studies (2, 
17) (which were combined in the original study (16)), as these were enrolled under strict 
inclusion criteria whereas observational studies would be more inclusive. To demonstrate 
the random effect variance in respect to the depression prevalence, we displayed the 
intraclass correlation coefficient, which shows what part of the total variance in 
prevalence is between studies. To investigate whether cardiovascular disease indices and 
other risk factors accounted for any sex differences in depression, a linear mixed model 
with random intercept was used, with depression z-scores as the dependent variable, and 
sex, disease indices and their interaction as predictors, adjusting for age. For each disease 
index a separate model was built. A contrast coding of -0.5/0.5 for dichotomous variables 
was used in the Cox regression analyses to ensure between-study variances between 
groups were equal (e.g. female vs. male) (18). Separate models were built for each 
disease and risk factor index. Also, two more multivariate models were built – including 
all disease and risk factors, but omitting LVEF, together as covariates, and then a final 
model including all disease and risk factors. To increase confidence interval robustness, 
and in view of the non-normal distribution of the depression z-scores, bootstrapping with 
1000 replications was used in all analyses (19). The handling of the variables used for 
adjustment and the applied outcomes was identical to that in the main MINDMAPS study 
(16). All tests were two-tailed. 
 
Results 
Sample description 
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Of 30 eligible studies (16), 16 provided individual patient data (see supplementary 
Table S1 for an overview of participating studies). These studies were from 9 different 
countries. The description of the combined sample (N=10,175), stratified by sex, is 
displayed in Table 1: 
 
-------- 
Insert Table 1 here 
-------- 
 
Overall, the mean age was 61 years (range 20-97), 71% of participants were men, and 
mean follow-up time per study was 3.15 years (range 0.96 – 6.65). 
 
Prevalence of depression 
Data from four diagnostic interview studies (omitting the ENRICHD data, n=900) 
showed that 20% (47/240) of women and 12% (76/660) of men had major depression. 
The age-adjusted multilevel logistic regression showed this to be a significant difference 
(OR=0.42, 95% CI 0.27 to 0.65, p=0.001). There was little heterogeneity between these 
interview studies in depression prevalence: the intraclass correlation coefficient was 0.01 
(Chi2 = 1.4; p=0.12). 
 
When using the data from the questionnaire studies, excluding data from the ENRICHD 
and ancillary studies (fourteen studies; n=7202), the sex differences in prevalence 
remained significant (age-adjusted OR=0.69, 95% CI 0.61 to 0.77, p<0.001), with a 
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higher percentage of women scoring above recommended thresholds for “clinically 
significant” depressive symptoms (38%, 657/1741) than men (30%, 1622/5461). There 
was some heterogeneity between these questionnaire studies in depression prevalence: 
the intraclass correlation coefficient was 0.10 (Chi2(1) = 436.3; p<0.001). This implies 
that 10% of the total variance in depression prevalence is due to differences between 
studies. 
 
Combining the interview and questionnaire studies, but omitting the ENRICHD data 
(fifteen studies; n=7286), resulted in 36% (635/1760) of women and 29% (1575/5526) of 
men reporting elevated depressive symptoms (age-adjusted OR=0.68, 95% CI 0.60 to 
0.77, p<0.001). The intraclass correlation coefficient was 0.14 (Chi2(1) = 547.7; 
p<0.001), indicating significant, though not large, heterogeneity between studies in 
depression prevalence.  
 
We also checked whether the sex difference in depression prevalence varied with age. 
We did so by including an interaction term sex*age in the above analysis. The interaction 
was not significant (OR=1.00, 95% CI 0.99 to 1.01, p = 0.91). So, the sex difference in 
depression prevalence did not vary with age. The main effect of age on the prevalence 
of depression, adjusted for sex, was small and not significant (OR=0.99, 95% CI = 
0.99 to 1.00, p = 0.069). 
 
Disease severity 
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Various disease indices and risk factors were analysed to determine if these accounted for 
sex differences in depression scores. Interactions between sex and history of MI, Killip 
class, diabetes, smoking or BMI were not associated with depression z-scores 
(Supplementary Table S2). However, an interaction between sex and left ventricular 
ejection fraction was observed (see the upper panel of Table 2):   
 
-------- 
Insert Table 2 here 
-------- 
 
This interaction remained significant when adjusting for all other disease factors and risk 
indices (see the lower panel of Table 2). The results suggest that for men only, low LVEF 
was associated with higher levels of depression.  
 
Moderation effects of sex in the association between depression and prognosis 
Survival curves for all-cause mortality and depression status, and cardiovascular events 
and depression status are shown in Fig 1: 
 
---------- 
Insert Fig 1 about here 
---------- 
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The survival curves show that depression was related to poorer prognosis, in both men 
and women, and that the effect is more important in men. This is further investigated in 
Table 3:  
 
-------- 
Insert Table 3 here 
-------- 
 
The Cox regression analyses for all-cause mortality showed that the interaction between 
sex and depression was statistically significant (HR for interaction=1.12; 95% CI: 1.05 to 
1.19, p<0.001), suggesting that the association between depression and mortality was 
indeed stronger for men than for women. The HR associated with depression was 12% 
higher in men compared to women (men, HR=1.38, 95% CI 1.30 to 1.47, p<0.001; 
women, HR=1.22, 95% CI 1.14 to 1.31, p<0.001). Omitting data from the ENRICHD 
studies had little effect on the interaction term (HR for interaction=1.10, 95% CI 1.02 to 
1.19, p=0.014). The interaction effect for CVE pointed into the same direction, but did 
not reach significance.  
 
We also checked whether the sex difference in the impact of depression on cardiovascular 
outcomes varied with age. We did so by including an interaction term 
sex*age*depression in the above analyses. The interaction was not significant (all-cause 
mortality HR =1.00. 95% CI 0.99 to 1.01, p = 0.92; CVE: HR =1.00. 95% CI 0.99 to 
1.00, p = 0.59; Supplementary Table S2). So, the sex difference in the impact of 
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depression on cardiovascular outcomes did not vary with age. The sex*depression 
interaction now did reach significance also in the CVE model (p = 0.038). 
 
Because sex differences between depression and cardiac prognosis may be 
dependent on post-menopausal status (20, 21), we did a sensitivity analysis repeating 
the analysis of Table 3 but now separately for individuals aged younger and older 
than 55 years. This did not yield different results. The sex*depression interaction in 
the prediction of all-cause mortality was significant in both age groups (age<=55, 
HR=1.20, 95% CI 1.01 to 1.43, p=0.038; age>55, HR=1.11, 95% CI 1.03 to 1.20, 
p=0.005). The HR for the sex*depression interaction in the prediction of CVE 
pointed in the same direction but was non-significant in both age groups (age<=55, 
HR=1.15, 95% CI 0.94 to 1.41, p=0.18; age>55, HR=1.05, 95% CI 0.90 to 1.23, 
p=0.51). 
 
Finally, we determined if the moderating effect of sex in the association between 
depression and all-cause mortality could be explained by the cardiovascular disease 
indices or risk factors. The same multilevel Cox regression analyses were used, 
predicting all-cause mortality by age, depression, sex, and sex*depression. Then, the size 
of the change in the estimate for the interaction sex*depression was determined when 
each of the disease variables was included in these separate models, and in two 
multivariate models. Results are shown in Table 4: 
 
-------- 
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Insert Table 4 here 
-------- 
 
In the separate models, LVEF accounted for the largest reduction in the size of the 
sex*depression interaction, and inclusion of this variable resulted in a non-significant 
interaction. History of MI also accounted for a substantial reduction in the interaction, but 
most other factors increased instead of reduced the size of the interaction. These 
differences could be the result of differences between studies or sample sizes, therefore, 
the analyses were repeated with only those participants who had data on all six 
cardiovascular disease variables and risk indices (History of MI, LVEF, and Killip class, 
diabetes, smoking, BMI). The last rows of Table 4 show the results of the multivariate 
models. While adjusting for all covariates except LVEF (5172 participants in 5 studies) 
resulted in an 8% increase in the sex*depression interaction, inclusion of all six 
covariates (2226 participants in 3 studies) resulted in a 32.5% reduction of the 
sex*depression interaction effect, and resulted in a non-significant interaction. Together, 
these results suggest that the moderating effect of sex on the association between 
depression and all-cause mortality can partially be explained by differences in LVEF and 
history of MI among depressed men and women, and that LVEF explained the largest 
part of the sex*depression interaction. 
Furthermore, despite there being no statistically significant sex*depression interaction in 
the cardiac disease and risk factor-adjusted models for predicting CVE, the 
percentage reduction of the interaction term was again largest for LVEF, showing a 
consistency across outcomes (results not shown).   
13 
 
 
Discussion 
In this largest study to date, we found a number of results that are important in 
interpreting the association between post-MI depression and prognosis. Firstly, low 
LVEF was associated with depressive symptoms, but only in men. Secondly, the 
association between depression and prognosis was stronger in men than in women, which 
could partly be explained by depressive symptoms being a reflection of low LVEF more 
often for men than for women. LVEF attenuated the interaction effect between depression 
and sex in the prediction of prognosis. 
 
In general, the prevalence of depression by diagnostic interview and questionnaire studies 
are similar to that previously reported (8), with higher proportions of women having 
depression according to both diagnostic interview and questionnaire studies. This higher 
prevalence of depression in women, added to the fact that depression was associated with 
disease severity in men only, demonstrates how depression in this population mimics 
depression in the general population. Other studies have also demonstrated how 
psychosocial risk factors for depression are predictors not only of elevated post-MI 
depressive symptomatology, but also of trajectories of depression post-discharge (9-13, 
22), suggesting that depressive symptoms cannot be attributed solely to coronary disease 
severity. However, the higher prevalence of depression reported using scale thresholds 
rather than interview techniques again provides evidence that psychometric scales 
overestimate the prevalence of depression in this population, with our findings 
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demonstrating 2.5- to 3-fold higher prevalence, as found previously (8). This higher 
prevalence by questionnaire probably represents confounding between somatic symptoms 
of depression and symptoms of coronary disease (14, 15, 23), which cannot easily be 
thoroughly investigated as may happen during a diagnostic interview. Conversely, it has 
been demonstrated that even low levels of depression predict cardiovascular prognosis 
(24), thus relying on diagnostic interviews may actually underestimate meaningful levels 
of depression. Furthermore, while it has previously been suggested that the higher 
prevalence of depression in women might lead to poorer cardiovascular prognosis (25), 
we have found no evidence for this. Indeed, depression was more strongly related to a 
worse cardiac prognosis in men than in women. Single studies may not have had the 
power to detect such effects.  
 
Depression was associated with a poor LVEF in men but not in women. Poor LVEF has 
been associated with depression in patients with coronary disease (26, 27). Previously, 
van Melle et al. (14) have shown that in 1989 post-MI patients LVEF was inversely 
correlated with depression status (from diagnostic interviews) and depression scale scores 
at several time points in the year post-MI, even in those who did not demonstrate 
depression at baseline. Furthermore, men demonstrated a trend towards a stronger 
increase in rates of depression across more severe LVEF categories, which was 
confirmed in the present findings. The data from that sample were included in the present 
analyses. However, that was a single study, while the present analyses are from 16 
studies. That depression was more strongly related to prognosis for men may be 
explained by the differential nature of MI in women and men. Women with MI tend to be 
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older by approximately 10 years, have more diffuse coronary disease, have non-ST-
elevation MI thereby not being eligible for emergency primary percutaneous coronary 
intervention (21, 28) which is protective of subsequent lowering of LVEF (29-31), and 
therefore have worse hospital outcomes (28, 29). Men tend to have more focal lesions 
that result in ST-elevation MI. In the current data, women were less likely to receive 
percutaneous coronary intervention. As a result, women are more likely to end up with 
heart failure with preserved ejection fraction while men end up with heart failure with 
reduced ejection fraction (29-31). Thus, the differential attenuation by LVEF of the 
association of depression with outcomes may be partly explained by the fact that women 
are less likely to have the type of MI that results in a low LVEF. Further research is 
needed to clarify this possibility. Alternatively, the etiology of depression in post-MI 
patients may differ in women and men. Men may be more likely to have depression as a 
result of coronary disease severity, while women may more often have pre-existing 
depression (32). These sex differences are perhaps unlikely to be mediated by other 
biological (e.g. reduced cardiac autonomic tone, increased platelet aggregation, increased 
inflammatory processes) (33, 34) or behavioral (e.g. smoking, physical inactivity etc.) 
(34-36) mechanisms linking depression to MI, as no consistent links with men or women 
have been reported. Recent research also suggests that fetal exposure may have increased 
the risk of both depression and cardiovascular disease, and that this effect is stronger in 
women (37), although this requires further investigation. The lack of variation in results 
in the sensitivity analysis was perhaps surprising given that younger women have 
consistently been shown to have poorer prognosis than younger men (21). This may 
be due to the fact that there were relatively few young women in each study included 
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here, and that these studies took place over a large timeframe, perhaps making them 
less representative than larger registry studies, or that using age thresholds is too 
crude to represent actual menopausal status. It is unclear why there was not a 
significant moderating effect of sex in the association between depression and CVE. One 
reason may be that CVE is a less well-defined endpoint across the studies, and this may 
lead to measurement error, or that there were different numbers and types of studies and 
participants analysed for this outcome.  
 
Limitations and strengths 
The heterogeneity of study populations, depression, cardiovascular risk factor 
measurements, and endpoint assessments may be problematic, although the inclusion of 
the random intercept accounts for study differences. Measures of distress have been 
shown to demonstrate measurement invariance across sex and ethnic groups in a large 
cross-sectional study (38). All-cause mortality includes non-cardiac deaths, and may bias 
the results. The heterogeneity of cardiovascular risk factors reported in individual studies 
meant that full adjustment could not be made in the overall sample. Inclusion of variables 
such as New York Heart Association categorisation, diastolic function, blood pressure, 
and cholesterol were not included in the dataset, but might have changed the results. 
Similarly, psychiatric history was unavailable, as was alcohol abuse, and other non-
cardiac co-morbidities or their treatments may also impact on the findings. Not all 
relevant studies were available for analysis (16), which may have biased the results, 
although most did not report sex differences or did not find any differences in prognosis.  
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Another major limitation of the present research, and indeed other studies in this area, is 
the lack of a plausible model that could explain the effects seen in this study. Other 
researchers have rightly called for more conceptual and theoretical clarity in the analysis 
of observational studies which investigate risk factors in disease etiology (39, 40). To 
establish any single variable as a true independent risk factor, confounder or mediator for 
a given outcome, knowledge of temporal precedence of variables is required (39, 40). 
This is extremely difficult in the case of cardiovascular disease and depression. In the 
present analyses we cannot, for example, assume that depression precedes LVEF, or vice 
versa, as this data simply was not available to us. We have therefore avoided the terms 
‘mediate’ or ‘confound’, etc. Further research with repeated measures of important 
variables is required before true risk factors and mediators of sex differences in 
depression and prognosis post-MI are elucidated. 
 
The major strength of the study is the use of individual patient data, which allows for 
time-to-event analysis, and adjustment for potentially confounding variables 
systematically across studies, which cannot be done in summary meta-analyses, resulting 
in more accurate estimates of effect sizes, increased statistical power, generalizability and 
reliability of results (41). The inclusion of the random intercept term allows important 
between-study differences to be accounted for statistically, such as changing acute 
treatments (percutaneous coronary intervention has superseded thrombolysis in the 
timeframe spanned by the present studies) (29, 30), or differential assessment of LVEF – 
18 
 
which may impact on its prognostic ability (42, 43). The ability to analyse both interview 
and questionnaire studies is a strength, and the results demonstrated consistent patterns 
across these methods.  
 
Conclusions 
Using IPD from a large sample, the present study revealed significant differences in the 
prevalence, possible etiology and consequences of depression post-MI in men versus 
women. The prevalence of depression post-MI was higher in women than men, but the 
association between depression and cardiac prognosis was worse for men. LVEF was 
associated with depression in men only, and accounted for the increased risk of all-cause 
mortality in depressed men, suggesting that depression in men post-MI may in part reflect 
cardiovascular disease severity. Future studies, including intervention studies, should 
account for these sex differences. 
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Table 1: Baseline characteristics by sex 
 Men (n=7200) Women (n=2975) p-value N measured 
Demographic 
characteristics 
    
Age (mean, (SD)) 59.7 (11.5) 64.1 (12.2) <0.001*** 10,171 
Employment status (% 
employed) 
53.6 27.0 <0.001*** 6,528 
Partner status (% with 
partner) 
77.5 51.4 <0.001*** 6,412 
Cardiac disease severity     
History of MI (% yes) 19.2 18.0 <0.001*** 9,646 
LVEF (% of patients <40%) 22.6 22.4 0.56 3,505 
Killip class (% poor) 16.1 22.9 <0.001*** 7,532 
PTCA (%) 47.2 42.1 <0.001*** 7,679 
History of PTCA (%) 11.4 11.0 0.11 4,830 
CABG (%) 9.8 9.3 <0.001*** 8,139 
History of CABG (%) 10.8 7.9 <0.001*** 4,849 
Thrombolysis (%) 33.8 34.0 0.061 8,065 
Congestive HF (%) 17.2 24.3 0.013* 6,104 
Other risk factors     
Diabetes (%) 18.0 29.8 <0.001*** 10,060 
Smoking (%) 49.5 32.8 <0.001*** 9,942 
BMI (mean, (SD)) 26.8 (4.5) 27.8 (6.0) 0.002** 7,188 
Hyperlipidemia / 
hypercholesterolemia (%) 
45.3 50.2 <0.001*** 8,405 
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Hypertension (%) 31.6 38.6 <0.001*** 8,301 
History of hypertension (%) 43.1 62.2 <0.001*** 5,348 
Medication use     
Hypolipidemics (%) 43.5 44.1 0.29 4,004 
Beta-blockers (%) 72.3 71.2 0.003** 8,833 
Aspirin (%) 87.2 87.2 0.49 7,561 
Calcium-channel blockers / 
antagonists (%) 
14.5 21.3 <0.001*** 7,056 
ACE-inhibitors (%) 48.7 49.8 0.26 8,550 
Antidepressant use (%) 5.8 8.1 0.013* 5,507 
Study type     
Diagnostic interview (n) 660 240  900 
Questionnaire (n) 7108 2942  10,050 
ACE: angiotensin converting-enzyme; BMI: body mass index; CABG: coronary artery bypass graft; HF: heart failure; 
LVEF: left ventricular ejection fraction; MI: myocardial infarction; PTCA: percutaneous transluminal coronary 
angioplasty; SD: standard deviation 
***p < 0.001; **p < 0.01; *p < 0.05 
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Table 2: Linear mixed model with random intercept for study, predicting depression z-
score (n=3115, 5 studies) 
 B Bootstrapped 95% CI p 
Adjusted for age (n=3115, 5 studies)    
Age -0.001 -0.004 – 0.002 0.57 
LVEF -0.015 -0.191 –  0.161 0.87 
Sex -0.371 -0.476 –  -0.265 <0.001*** 
Sex*LVEF 0.294 0.090 –  0.498 0.005** 
Adjusted for all confounders (n=2226, 3 studies) 
Age -0.002 -0.008 – 0.003 0.36 
History of MI 0.148 0.064 – 0.233 0.001** 
Killip class 0.132 0.029 – 0.235 0.012* 
Diabetes 0.145 0.059 – 0.231 0.001** 
Smoking 0.057 0.024 – 0.090 0.001** 
BMI -0.011 -0.028 – 0.006 0.21 
LVEF -0.019 -0.089 – 0.052 0.61 
Sex -0.348 -0.426 – -0.269 <0.001*** 
Sex*LVEF 0.274 0.061 – 0.488 0.012* 
***p < 0.001; **p < 0.01; *p < 0.05.  Sex (0=female, 1=male) 
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Table 3: Multilevel Cox proportional hazards regression assessing sex differences in the 
association between depression and cardiovascular prognosis 
 All-cause mortality 
(n=7628, 10 studies) 
Cardiovascular events (CVE) 
(n=6556, 7 studies) 
 HR Bootstrapped 
95% CI 
P HR Bootstrapped 
95% CI 
P 
Age 1.07 1.06 – 1.08 < 0.001*** 1.01 1.01 – 1.02 < 0.001*** 
Depression z-
score 
1.30 1.24 –  1.37 < 0.001*** 1.17 1.13 –  1.22 < 0.001*** 
Sex 1.07 0.90 – 1.28 0.44 0.93 0.78 – 1.11 0.42 
Sex * 
depression z-
score 
1.12 1.05 – 1.19 < 0.001*** 1.07 0.98 – 1.17 0.118 
***p < 0.001; **p < 0.01; *p < 0.05. Sex (-0.5=female, 0.5=male) 
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Table 4: Percentage change in sex*depression interaction effects in the prediction of all-
cause mortality by additional disease indices or risk factors  
Factor HR for 
interaction 
sex*depression 
Adjusted HR for 
interaction 
sex*depression 
% change N/n studies 
History of MI  1.097*** 1.088** -8.9% 7543/10 
LVEF 1.126* 1.086 -30.5% 3115/5 
Killip class  1.137*** 1.162*** +16.9% 5924/6 
Diabetes 1.107*** 1.130*** +20.2% 7587/10 
Smoking 1.118** 1.119** +0.8% 7485/10 
BMI 1.128** 1.125** -2.2% 6133/7 
Adjusting for 
all covariates 
except LVEF 
1.140*** 1.152** +8.0% 5172/5 
Adjusting for 
all covariates 
1.107** 1.071 -32.5% 2226/3 
Adjusted for age, depression z-score, and sex, with study as a random factor 
Note: The percentage change was estimated by using the log HR for the sex*depression 
interaction effect.  
***p < 0.001; **p < 0.01; *p < 0.05 
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Figure Legends  
 
 
Figure 1: Survival curves for all-cause mortality (ACM) and cardiovascular events (CVE), by 
depression category and sex (adjusted for age). depr = depression. Depression categories are 
based on a split-half of the continuous depression z-scores on self-report questionnaires.  (Note: 
In all Cox regression analyses, the continuous depression z-score is used.) 
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Supplementary Table S1: Overview of participating studies 
PI, study name, 
country 
Start 
of 
study 
N
3
 / % 
Women 
(n 
women) 
Inclusion criteria Exclusion criteria Mean 
age 
(SD) 
Depression 
measurement 
instrument
1
 
and cut-off 
score 
N / % 
depre
ssed 
Mean 
depression 
score (SD) 
Mean 
follow-up 
time (days) 
No. of 
events 
ACM / 
CVE 
R. Carney, J. A. 
Blumenthal 
ENRICHD and  
ancillary HRV 
study
2
 
USA (1-3)  
1996 
/ 
1997 
2848 / 
42% 
(1196) 
standardized criteria 
for MI; 
low social support or 
depression 
ancillary study: no 
depression or social 
isolation, otherwise 
eligible for ENRICHD 
other life-threat. 
med. illn.; cogn. 
impairm.;  too ill; 
other major psych. 
disord.; 
unable/refused to 
participate 
61 
(12.3) 
BDI-1A ≥ 10 1951 / 
69% 
14.13 (8.87) ACM: 834 
CVE: 609 
ACM: 350 
CVE: 1151 
J. Ormel, P. de 
Jonge, 
MIND-IT 
The Netherlands 
(4) 
1999 1814 / 
23% 
(417) 
standardized criteria 
for MI 
age ≥ 18 
other life-threat. 
med. illn.; MI during 
hosp. for other 
reason;  psych. 
depr. treatm; part. 
in conflicting clin. 
trial  
61 
(11.6) 
BDI 1-A ≥ 10 BDI: 
474 / 
26% 
6.77 (6.18) ACM: 2167 
CVE: 1517 
ACM: 278 
CVE: 784 
J. Ormel, P. de 
Jonge 
DepreMI 
The Netherlands 
(5)  
1997 528 / 
19% 
(100) 
standardized criteria 
for MI 
other life-threat. 
med. illn.; cogn. 
impairm.; too ill; 
unable to 
communicate; MI 
61 
(11.7) 
modified 
Dutch version 
of CIDI 2.1  
 
BDI 1A ≥ 10 
CIDI: 
73 / 
15% 
 
BDI: 
6.80 (6.12) ACM: 2663 
CVE: 1851 
ACM: 116 
CVE: 237 
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during hosp. for 
other reason 
117 / 
23% 
J. Denollet 
 
The Netherlands 
(6)  
2003 501 / 
22% 
(110) 
Standardized criteria 
for MI;  
Age > 30  
other life-threat. 
med. illn.; cogn. 
Impairm.  
60 
(11.6) 
BDI-1A ≥ 10 132 / 
26% 
7.03 (6.18) ACM: 1374 
CVE: 1284 
ACM: 38 
CVE: 82 
F. Doyle, H. M. 
McGee 
 
Ireland(7)  
2003 433 / 
25% 
(108) 
standardized criteria 
for ACS (only MI 
patients were 
included in the IPD 
meta-analysis) 
nr 63 
(12.3) 
HADS-D > 7 
BDI-FS > 3 
HADS-
D or 
BDI-
FS: 75 
/ 17% 
HADS-D: 
4,14 (3,26) 
BDI-FS: 1.88 
(2.69) 
ACM: 356 
CVE: na 
ACM: 17 
CVE: na 
F. Doyle, H.M. 
McGee 
  
Ireland(8) 
2006 285 / 
20% 
(57) 
standardized criteria 
for ACS (only MI 
patients were 
included in the IPD 
meta-analysis) 
patient too 
distressed 
61 
(10.9) 
HADS-D > 7 
BDI-FS (6-
item) > 3 
either 
HADS-
D or 
BDI-
FS: 78 
/ 27%  
HADS-
D: 33 / 
12%; 
BDI-FS 
69 / 
24% 
HADS-D: 
3,52 (3,07) 
BDI-FS: 2.15 
(2.84) 
ACM: 427 
CVE: 427 
ACM: 19 
CVE: 67 
S. Bergerone 
 
Italy(9) 
1999 98 / 
22% 
(22) 
standardized criteria 
for MI 
in-hosp. mort.; 
other major psych. 
disord.; alcoholism; 
antidepr. therapy 
62 
(12.6) 
struct. int. 
based on 
DSM-IV 
criteria 
BDI 1A ≥ 10 
MDD: 
14 / 
14% 
BDI: 
35 / 
34% 
BDI: 8.34 
(8.48) 
ACM: 1485 
CVE: 1485 
ACM: 6 
CVE: 29 
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S.H. Hosseini 
 
Iran(10) 
2004 540 / 
31% 
(167) 
standardized criteria 
for MI 
other life-threat. 
med. illn.; MI result 
of CABG or angiogr.; 
too ill 
58 
(12.0) 
BDI 1A ≥ 10 355 / 
66% 
14.20 (9.80) na (24 
months) 
ACM: 
naCVE: 55 
D.A. Lane 
 
UK(11, 12)  
1997 288 / 
25% 
(72) 
standardized criteria 
for MI 
other life-threat. 
med. illn.; cogn. 
impairm.; MI result 
of CABG or angiogr.; 
unable to 
communicate; too 
ill 
63 
(11.5) 
BDI 1A ≥ 10 89 / 
31% 
7.72 (6.26) ACM: 976 
CVE:na 
ACM: 38 
CVE: na 
L. Pilote 
 
Canada(13)  
1996 553 / 
19% 
(105) 
acute MI; surv. up to 
24 hours after hosp. 
adm.; adm. through 
emergency dept. 
phys. unable to 
respond to quest.; 
unable to 
communicate 
60 
(12.2) 
BDI 1  ≥10 193 / 
35% 
9.07 (7.93) ACM: 350 
CVE: 205 
ACM: 32 
CVE: 222 
K. Parakh, R.C. 
Ziegelstein 
 
USA (14)  
1995 284 / 
43% 
(122) 
standardized criteria 
for MI 
other life-threat. 
med. illn.; cogn. 
impairm.; too ill 
65 
(12.1) 
SCID 
 
BDI 1A ≥10 
MDD: 
29 / 
10% 
BDI: 
56 / 
20% 
BDI: 5.76 
(6.15) 
ACM: 2428 
CVE: na 
ACM: 153 
CVE: na 
C. Rafanelli 
 
Italy(15)  
1995 61 / 
15% (9) 
standardized criteria 
for MI; first MI 
nr 59 
(9.9) 
modified SCID 
(minor and 
major 
depression 
7 / 
11% 
na na (24 
months) 
ACM: 4 
CVE: 22 
H. Sato 
OACIS 
Japan(16)  
1998 1042 / 
20% 
(208) 
standardized criteria 
for MI 
in-hosp. mort.; 
other major psych. 
disord.;  unable to 
communicate 
63 
(11.2) 
ZSDS ≥ 40 438 / 
42% 
38.03 (9.07) na (12 
months) 
ACM: na 
CVE: 283 
R.P. Steeds 
 
1999 131 / 
67% 
MI; age < 75 nr 60 BDI-II ≥ 14 52 / 12.42 (9.09) ACM: 457 ACM: 11 
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UK(17)  (88) (9.4) 40% CVE: na CVE: na 
S.L. Grace 
 
Canada(18)  
1997 468 / 
28% 
(131) 
confirmed MI; age ≥ 
18 
too ill; unable to 
communicate 
61 
(12.2) 
BDI 1A  ≥ 10 136 / 
28% 
7.93 (7.22) na (12 
months) 
ACM: 29 
CVE: 101 
C. Welin 
 
Sweden(19)  
1985 270 / 
16% 
(43) 
standardized criteria 
for MI; first MI; age < 
65 
nr 56 
(7.0) 
ZSDS ≥ 40 96/ 
36% 
36.76 (8.58) na (120 
months) 
ACM: 65 
CVE: 73 
1
 Depression measurement instrument used in the current individual patient data meta-analysis. 
2
 Part of the non-depressed control group came from an ancillary study and part of the patients in the non-depressed control group had low social support. 
Depressed patients were oversampled for the purpose of the study. 
3 Number of patients included in IPD-meta-analysis. 
Abbreviations: ACM: All-cause mortality; ACS: acute coronary syndrome; BDI: Beck Depression Inventory; BDI-FS: Beck Depression Inventory Fast Scale; CIDI: 
Composite International Diagnostic Interview; CVE: cardiovascular events; DepreMI: Depression after Myocardial Infarction; ENRICHD: Enhancing Recovery in 
Coronary Heart Disease; HADS-D: Hospital Anxiety and Depression Scale-Depression subscale; HRV: heart rate variability; MDD: major depression disorder; MI: 
myocardial infarction; MIND-IT: Myocardial Infarction and Depression Intervention Trial; na: not available; nr: not reported; OACIS: Osaka Acute Coronary 
Insufficiency Study; PI: primary investigator; SCID: Structured Clinical Interview for DSM; SD: standard deviation; ZSDS: Zung Self-rating Depression Scale 
 
Note: Most data in Supplementary Table 1 has been reproduced with permission from the original MINDMAPS study 
published in the British Journal of Psychiatry (Meijer A, Conradi HJ, Bos EH, Anselmino M, Carney R, Denollet J, Doyle F, 
Freedland KE, Grace SL, Hosseini SH, Lane DA, Pilote L, Parakh K, Rafanelli C, Sato H, Steeds RP, Welin C, de Jonge 
P. Adjusted prognostic association of post-myocardial infarction depression with mortality and cardiovascular events: an 
36 
 
individual patient data meta-analysis. Br J Psychiat. 2013;203:90-102. http://bjp.rcpsych.org/content/203/2/90.short). The 
authors gratefully acknowledge this permission.  
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Supplementary Table S2: Interactions between sex and disease indices and other 
risk factors in the prediction of depression z-scores 
 B Bootstrapped 95% 
CI 
p N/n studies 
Sex*History of MI 0.080 -0.051 – 0.212 0.23 7543/10 
Sex*LVEF 0.294 0.090 – 0.498 0.005** 3115/5 
Sex*Killip class 0.066 -0.210 – 0.078 0.37 5924/6 
Sex*Diabetes -0.045 -0.166 – 0.075 0.46 7587/10 
Sex*Smoking 0.002 -0.101 – 0.105 0.97 7485/10 
Sex*BDI -0.008 -0.018 – 0.002 0.13 6133/7 
Linear mixed models with random intercept, with z-depression scores as dependent variable, and sex, 
disease index/risk factor, and their interaction as predictors, adjusting for age.**p<0.01. Sex 
(0=female, 1=male) 
2 
 
Supplementary Table S3: Multilevel Cox proportional hazards regression assessing 
sex and age differences in the association between depression and cardiovascular 
prognosis 
 All-cause mortality 
(n=7628, 10 studies) 
Cardiovascular events (CVE) 
(n=6556, 7 studies) 
 HR Bootstrapped 
95% CI 
P HR Bootstrapped 
95% CI 
P 
Age  1.07 1.07 – 1.08 < 0.001*** 1.01 1.01 – 1.02 < 0.001*** 
Depression z-
score 
1.32 1.21 –  1.43 < 0.001*** 1.19 1.13 –  1.26 < 0.001*** 
Sex 0.89 0.77 – 1.04 0.44 0.53 0.23 – 1.22 0.14 
Sex * 
depression z-
score 
1.14 1.05 – 1.24 < 0.001*** 1.09 1.00 – 1.17 0.038* 
Age * 
depression z-
score 
1.00 1.00 – 1.01 0.58 1.00 1.00 – 1.00 0.50 
Sex * age 1.02 1.01 – 1.03 < 0.001*** 1.01 1.00 – 1.02 0.17 
Sex * age * 
depression z-
score  
1.00 0.99 – 1.01 0.92 1.00 0.99 – 1.00 0.59 
***p < 0.001; **p < 0.01; *p < 0.05.  
Note. Age and sex are grand-mean centered in this analysis, to facilitate interpretation of 
the main effects 
 
3 
 
 
References for supplementary Table S1 
1. Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de Jonge P, 
Davidson KW, Czajkowski SM, Jaffe AS. History of depression and survival after 
acute myocardial infarction. Psychosom Med. 2009;71:253-9. 
2. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, 
Czajkowski SM, O'Connor C, Stone PH, Freedland KE. Depression, heart rate 
variability, and acute myocardial infarction. Circulation. 2001;104:2024-8. 
3. The ENRICHD Investigators. Enhancing recovery in coronary heart 
disease patients (ENRICHD): study design and methods. Am Heart J. 
2000;139:1-9. 
4. van den Brink RH, van Melle JP, Honig A, Schene AH, Crijns HJ, Lambert 
FP, Ormel J. Treatment of depression after myocardial infarction and the effects 
on cardiac prognosis and quality of life: rationale and outline of the Myocardial 
INfarction and Depression-Intervention Trial (MIND-IT). Am Heart J. 
2002;144:219-25. 
5. de Jonge P, van den Brink RH, Spijkerman TA, Ormel J. Only incident 
depressive episodes after myocardial infarction are associated with new 
cardiovascular events. J Am Coll Cardiol. 2006;48:2204-8. 
6. Denollet J, Martens EJ, Smith OR, Burg MM. Efficient assessment of 
depressive symptoms and their prognostic value in myocardial infarction patients. 
J Affect Disord. 2010;120:105-11. 
7. Doyle F, McGee HM, De La Harpe D, Shelley E, Conroy R. The Hospital 
Anxiety and Depression Scale depression subscale, but not the Beck Depression 
4 
 
Inventory-Fast Scale, identifies patients with acute coronary syndrome at 
elevated risk of 1-year mortality. J Psychosom Res. 2006;60:461-7. 
8. Doyle F, Conroy R, McGee H, Delaney M. Depressive symptoms in 
persons with acute coronary syndrome: specific symptom scales and prognosis. 
J Psychosom Res. 2010;68:121-30. 
9. Drago S, Bergerone S, Anselmino M, Varalda PG, Cascio B, Palumbo L, 
Angelini G, Trevi PG. Depression in patients with acute myocardial infarction: 
influence on autonomic nervous system and prognostic role. Results of a five-
year follow-up study. Int J Cardiol. 2007;115:46-51. 
10. Hosseini SH, Yousefnejad K, Tabiban S, Nesarhoseyni V, Bagheri B, 
Kiasari AM, Ghaemian A, Ghadirnejad SN, Lolati HA, Amiri FN, Ashraf H, 
Mokhberi V. Effects of depression and anxiety symptoms on cardiac mortality 
following myocardial infarction: a 2-year follow-up. Int J Psychiat Clin Pract. 
2011;15:91-6. 
11. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Do depression and 
anxiety predict recurrent coronary events 12 months after myocardial infarction? 
QJM. 2000;93:739-44. 
12. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and quality of 
life 12 months after myocardial infarction: effects of depression and anxiety. 
Psychosom Med. 2001;63:221-30. 
13. Lauzon C, Beck CA, Huynh T, Dion D, Racine N, Carignan S, Diodati JG, 
Charbonneau F, Dupuis R, Pilote L. Depression and prognosis following hospital 
admission because of acute myocardial infarction. CMAJ. 2003;168:547-52. 
5 
 
14. Parakh K, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein RC. Effect of 
depression on late (8 years) mortality after myocardial infarction. Am J Cardiol. 
2008;101:602-6. 
15. Rafanelli C, Milaneschi Y, Roncuzzi R, Pancaldi LG. Dysthymia before 
myocardial infarction as a cardiac risk factor at 2.5-year follow-up. 
Psychosomatics. 2010;51:8-13. 
16. Shiotani I, Sato H, Kinjo K, Nakatani D, Mizuno H, Ohnishi Y, Hishida E, 
Kijima Y, Hori M, Sato H. Depressive symptoms predict 12-month prognosis in 
elderly patients with acute myocardial infarction. J Cardiovasc Risk. 2002;9:153-
60. 
17. Steeds RP, Bickerton D, Smith MJ, Muthusamy R. Assessment of 
depression following acute myocardial infarction using the Beck depression 
inventory. Heart. 2004;90:217-8. 
18. Grace SL, Abbey SE, Pinto R, Shnek ZM, Irvine J, Stewart DE. 
Longitudinal course of depressive symptomatology after a cardiac event: effects 
of gender and cardiac rehabilitation. Psychosom Med. 2005;67:52-8. 
19. Welin C, Lappas G, Wilhelmsen L. Independent importance of 
psychosocial factors for prognosis after myocardial infarction. J Int Med. 
2000;247:629-39. 
 
 
 
